Hypertension (HTN) increases the risk of development of HF and it precedes it in 75% of cases. HF patients are nearly evenly divided between those with reduced left ventricular (LV) function or ...
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has reached a significant milestone in its Advance-HTN trial by hitting its enrollment target of 261 participants. This pivotal trial is ...
FRIDAY, Sept. 13, 2024 (HealthDay News) -- More than half of adults with uncontrolled hypertension are unaware that they have hypertension, according to a study published online Sept. 11 in JAMA ...
FRIDAY, Sept. 13, 2024 (HealthDay News) -- Predictive models for hypertension screening have been developed using speech recordings, with accuracies up to 84 percent for women and 77 percent for ...
Tech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, ...
The Iberis-HTN trial showed that in a Chinese cohort of uncontrolled primary HTN despite guideline-directed medical therapy, RDN with the AngioCare RF ablation system resulted in greater reductions in ...
GIRLS ——————– Team standings — 1. Houghton 18, 2. Negaunee 68, 3. Hancock 82, 4. Calumet 84, 5. Westwood 101. Ishpeming, Gwinn and West Iron County, no team scores ——————– Top finishers — 1. Tessa ...
The RADIANCE II (A Study of the ReCor Medical Paradise System in Stage II Hypertension) was a multicenter study that compared the safety and efficacy of ultrasound-based RDN with sham control among ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback